Published in J Neuroinflammation on November 17, 2010
Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence. Curr Probl Pediatr Adolesc Health Care (2014) 1.06
Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front Physiol (2014) 1.04
Focal brain inflammation and autism. J Neuroinflammation (2013) 1.03
Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity. J Neuroinflammation (2011) 1.03
Neuro-inflammation, blood-brain barrier, seizures and autism. J Neuroinflammation (2011) 0.97
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation. Clin Ther (2015) 0.95
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med (2015) 0.94
Perinatal stress, brain inflammation and risk of autism-review and proposal. BMC Pediatr (2012) 0.94
Markers of Celiac Disease and Gluten Sensitivity in Children with Autism. PLoS One (2013) 0.90
Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions. PLoS One (2012) 0.88
Traumatic Brain Injury and Peripheral Immune Suppression: Primer and Prospectus. Front Neurol (2015) 0.83
HLA Immune Function Genes in Autism. Autism Res Treat (2012) 0.82
Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes. Clin Med Insights Pediatr (2016) 0.82
Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation. Mediators Inflamm (2013) 0.81
Oxidized extracellular DNA as a stress signal in human cells. Oxid Med Cell Longev (2013) 0.81
Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder. J Neuroinflammation (2013) 0.80
Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin. J Neuroinflammation (2012) 0.80
Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders. Behav Sci (Basel) (2014) 0.79
Modeling autism: a systems biology approach. J Clin Bioinforma (2012) 0.79
Association of hypomelanotic skin disorders with autism: links to possible etiologic role of vitamin-D levels in autism? Hypothesis (Tor) (2011) 0.78
Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders. Transl Psychiatry (2016) 0.77
Association of human mtDNA mutations with autism in Iranian patients. J Res Med Sci (2013) 0.76
Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases. F1000Res (2017) 0.75
Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers. Metab Brain Dis (2017) 0.75
Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature (2010) 11.24
Mitochondria: dynamic organelles in disease, aging, and development. Cell (2006) 8.30
Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics (2009) 3.24
Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ (2009) 2.89
Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta (2008) 2.56
Elevated immune response in the brain of autistic patients. J Neuroimmunol (2009) 2.46
The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab (2008) 2.13
Mitochondrial disease: a practical approach for primary care physicians. Pediatrics (2007) 2.06
Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics (2009) 1.75
Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One (2008) 1.68
Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol (1999) 1.66
Autism and autism spectrum disorders: diagnostic issues for the coming decade. J Child Psychol Psychiatry (2009) 1.53
Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.45
The immune system's role in the biology of autism. Curr Opin Neurol (2010) 1.31
Mitochondrial dysfunction in autism spectrum disorders: cause or effect? Biochim Biophys Acta (2010) 1.18
Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann Clin Psychiatry (2009) 1.12
Using the Autism Diagnostic Interview-Revised and the Autism Diagnostic Observation Schedule-Generic for the diagnosis of autism spectrum disorders in a Greek sample with a wide range of intellectual abilities. J Autism Dev Disord (2008) 1.04
Autism and mitochondrial disease. Dev Disabil Res Rev (2010) 1.02
Neurotensin is increased in serum of young children with autistic disorder. J Neuroinflammation (2010) 1.01
Autism: an emerging 'neuroimmune disorder' in search of therapy. Expert Opin Pharmacother (2009) 0.95
Fever plus mitochondrial disease could be risk factors for autistic regression. J Child Neurol (2009) 0.92
Novel therapeutic targets for autism. Trends Pharmacol Sci (2008) 0.92
Enhancement of jejunal absorption of conjugated bile acid by neurotensin in rats. Gastroenterology (2001) 0.82
Involvement of mast cells in basal and neurotensin-induced intestinal absorption of taurocholate in rats. Am J Physiol Gastrointest Liver Physiol (2003) 0.81
Mast Cells, Mastocytosis, and Related Disorders. N Engl J Med (2015) 3.90
Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc (2002) 2.67
Risperidone-induced obsessive-compulsive symptoms: a series of six cases. J Clin Psychopharmacol (2002) 2.11
Mast cells and inflammation. Biochim Biophys Acta (2010) 1.91
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett (2003) 1.76
Neuroimmunology of stress: skin takes center stage. J Invest Dermatol (2006) 1.72
The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology (2007) 1.67
Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol (2005) 1.58
IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A (2010) 1.56
High levels of intrauterine corticotropin-releasing hormone, urocortin, tryptase, and interleukin-8 in spontaneous abortions. Endocrinology (2003) 1.52
Corticotropin-releasing hormone-receptor 2 is required for acute stress-induced bladder vascular permeability and release of vascular endothelial growth factor. BJU Int (2010) 1.46
Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol (2005) 1.45
Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in Apolipoprotein E knockout mice. Cardiovasc Res (2002) 1.45
Acute stress-induced seizures and loss of consciousness in a ten-year-old boy with cutaneous mastocytosis. J Clin Psychopharmacol (2002) 1.45
Chronic fatigue syndrome, mast cells, and tricyclic antidepressants. J Clin Psychopharmacol (2005) 1.44
The critical role of mast cells in allergy and inflammation. Ann N Y Acad Sci (2006) 1.43
Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol (2005) 1.31
Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther (2002) 1.23
Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology (2003) 1.14
Brain cytokines and neuropsychiatric disorders. J Clin Psychopharmacol (2004) 1.14
IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol (2003) 1.11
Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci U S A (2006) 1.10
Serotonin-selective reuptake inhibitors and nonsteroidal anti-inflammatory drugs--important considerations of adverse interactions especially for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Psychopharmacol (2011) 1.09
Spectrum of mast cell activation disorders. Expert Rev Clin Immunol (2014) 1.08
Advances in therapy with antileukotriene drugs. Ann Clin Lab Sci (2004) 1.07
Mast cell tryptase: a new biomarker in patients with stable coronary artery disease. Atherosclerosis (2005) 1.05
Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. World J Biol Psychiatry (2010) 1.03
Focal brain inflammation and autism. J Neuroinflammation (2013) 1.03
Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol (2011) 1.03
Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: relevance to atopic dermatitis. J Allergy Clin Immunol (2011) 1.02
Role of mast cells in tumor growth. Ann Clin Lab Sci (2007) 1.01
Neurotensin is increased in serum of young children with autistic disorder. J Neuroinflammation (2010) 1.01
Cytokines and other mediators in alopecia areata. Mediators Inflamm (2010) 0.99
A case of autophagia: a man who was mutilating his fingers by biting them. J Nerv Ment Dis (2012) 0.99
Mast cells in allergic and inflammatory diseases. Curr Pharm Des (2012) 0.95
Acute generalized exanthematous pustulosis (AGEP) triggered by a spider bite. Allergol Int (2009) 0.95
Effect of stress on brain inflammation and multiple sclerosis. Autoimmun Rev (2013) 0.95
Mast cell activation and autism. Biochim Biophys Acta (2010) 0.95
Mercury induces inflammatory mediator release from human mast cells. J Neuroinflammation (2010) 0.94
Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway. Mol Pharmacol (2005) 0.94
Perinatal stress, brain inflammation and risk of autism-review and proposal. BMC Pediatr (2012) 0.94
Manic/hypomanic symptoms induced by atypical antipsychotics: a review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.94
Aripiprazole in the treatment of tardive dyskinesia induced by other atypical antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.93
Skin corticotropin-releasing hormone receptor expression in psoriasis. J Invest Dermatol (2007) 0.92
Novel therapeutic targets for autism. Trends Pharmacol Sci (2008) 0.92
Contribution of stress to asthma worsening through mast cell activation. Ann Allergy Asthma Immunol (2012) 0.91
Factors affecting hospital stay in psychiatric patients: the role of active comorbidity. BMC Health Serv Res (2012) 0.90
Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br J Pharmacol (2006) 0.90
Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLoS One (2012) 0.90
Psychometric evaluation of the Fatigue Severity Scale in patients with major depression. Qual Life Res (2010) 0.89
Use of polyphenols in periodontal inflammation. Eur J Pharmacol (2013) 0.89
Obsessive-compulsive disorder associated with parietal white matter multiple sclerosis plaques. World J Biol Psychiatry (2009) 0.88
Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions. PLoS One (2012) 0.88
Mast cells squeeze the heart and stretch the gird: their role in atherosclerosis and obesity. Trends Pharmacol Sci (2011) 0.88
Niacin-induced "flush" involves release of prostaglandin D2 from mast cells and serotonin from platelets: evidence from human cells in vitro and an animal model. J Pharmacol Exp Ther (2008) 0.88
IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis. PLoS One (2012) 0.88
Cognitive decline and dementia in elderly medical inpatients remain underestimated and underdiagnosed in a recently established university general hospital in Greece. Arch Gerontol Geriatr (2009) 0.88
Mitochondria distinguish granule-stored from de novo synthesized tumor necrosis factor secretion in human mast cells. Int Arch Allergy Immunol (2012) 0.88